NCT06596746View on ClinicalTrials.gov

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

September 9, 2024

Primary Completion Date

September 9, 2034

Study Completion Date

September 9, 2034

Conditions
Neurodegenerative DiseasesParkinson DiseaseSynucleinopathiesLewy Body DiseaseMultiple System AtrophyTauopathiesAlzheimer DiseaseCorticobasal DegenerationSupranuclear Palsy, ProgressiveAtypical ParkinsonismTDP-43 ProteinopathiesAmyotrophic Lateral SclerosisFrontotemporal Lobar DegenerationMovement DisordersCognitive ImpairmentDementiaIron OverloadNeurodegeneration With Brain Iron Accumulation (NBIA)
Interventions
OTHER

Observation

In MARKERS-NDD up to 600 participants will be enrolled and followed longitudinally once identified, over the course of 1-10 years

Trial Locations (1)

03043

RECRUITING

San Raffaele Cassino, Cassino

All Listed Sponsors
collaborator

IRCCS San Raffaele Roma

OTHER

collaborator

San Raffaele Telematic University

OTHER

collaborator

"University of Urbino Carlo Bo"

OTHER

collaborator

University of Cassino and Southern Lazio

UNKNOWN

collaborator

University of Roma La Sapienza

OTHER

collaborator

Politecnico di Milano

OTHER

lead

Casa di Cura San Raffaele Cassino

NETWORK